دورية أكاديمية

Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma.

التفاصيل البيبلوغرافية
العنوان: Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma.
المؤلفون: Yasunobu Sekiguchi, Hiroki Tsutsumi, Ayumi Gomyo, Masahisa Kudo, Yoshie Iizaki, Nobuo Maseki, Machiko Kawamura, Kazuhiko Kobayashi, Yu Nishimura, Hiroaki Kanda, Hideaki Nitta, Masaaki Noguchi, Hirofumi Kobayashi
المصدر: Journal of Clinical & Experimental Hematopathology; 2023, Vol. 63 Issue 4, p262-265, 4p
قاعدة البيانات: Complementary Index
الوصف
تدمد:13464280
DOI:10.3960/jslrt.23043